{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:02:37Z","timestamp":1780470157648,"version":"3.54.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Obsessive\u2013compulsive disorder (OCD) frequently emerges during childhood and adolescence and has been associated with alterations in multiple neurobiological systems. Neuroendocrine pathways involved in stress regulation, neurodevelopment, metabolic signaling, and thyroid function interact closely to influence brain circuits implicated in OCD. However, studies simultaneously examining several neuroendocrine parameters in pediatric OCD remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case\u2013control study included 52 medication-free children and adolescents with OCD and 42 healthy controls aged 8\u201317 years. Psychiatric diagnoses were established using the Schedule for Affective Disorders and Schizophrenia for School-Age Children\u2014Present and Lifetime Version (K-SADS-PL) according to DSM-5 criteria. Obsessive\u2013compulsive symptom severity was assessed using the Children\u2019s Yale\u2013Brown Obsessive Compulsive Scale (CY-BOCS). Anxiety and depressive symptoms were evaluated using the Screen for Child Anxiety Related Emotional Disorders (SCARED) and the Children\u2019s Depression Inventory (CDI), respectively. Serum levels of adrenocorticotropic hormone (ACTH), cortisol, growth hormone (GH), Insulin-like growth factor-1 (IGF-1), Glucagon-like peptide-1 (GLP-1), relaxin-3 (RLN-3), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) were measured using ELISA. Group differences were examined using covariance-based models controlling for age, sex, BMI percentile, anxiety (SCARED), and depressive symptoms (CDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Initial analyses showed that children and adolescents with OCD had significantly lower serum levels of cortisol, IGF-1, GLP-1, and T3 compared with healthy controls. These differences remained significant after controlling for age, sex, BMI percentile, and the SCARED and CDI total score, with adjusted analyses showing lower levels of cortisol (p = 0.003), IGF-1 (p = 0.013), GLP-1 (p = 0.017), and T3 (p = 0.015) in the OCD group. Correlation analyses did not reveal significant associations between biochemical parameters and OCD symptom severity after correction for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that pediatric OCD may be associated with alterations in several neuroendocrine pathways rather than isolated changes within a single hormonal system. Further longitudinal studies are needed to better clarify the biological basis and clinical significance of these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1831156","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:06:47Z","timestamp":1780466807000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reduced serum cortisol, IGF-1, GLP-1, and T3 levels in medication-free children and adolescents with obsessive\u2013compulsive disorder: a case\u2013control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Fatma","family":"Co\u015fkun","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasibe","family":"A\u011f\u0131r","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukiye Esra","family":"Ild\u0131z","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necati","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"G\u00f6kta\u015f","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Osman","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Necmettin Erbakan University","place":["Konya, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","article-title":"Obsessive\u2013compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2011.09.008","article-title":"Etiology of obsessions and compulsions: a meta-analysis and narrative review of twin studies","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.154","article-title":"Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis","volume":"23","author":"Arnold","year":"2018","journal-title":"Mol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neubiorev.2016.03.011","article-title":"Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation","volume":"65","author":"Brander","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/21642850.2014.905207","article-title":"Trauma-related obsessive-compulsive disorder: a review","volume":"2","author":"Dykshoorn","year":"2014","journal-title":"Health Psychol Behav Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13895","article-title":"Neurometabolic dysregulation within the cortico-striatal-thalamo-cortical circuits in obsessive-compulsive disorder: a 1H-MRS meta-analysis","volume":"79","author":"Zhu","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000453664","article-title":"Effect of gonadal hormones on neurotransmitters implicated in the pathophysiology of obsessive-compulsive disorder: a critical review","volume":"105","author":"Karpinski","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-020-01690-6","article-title":"Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication-free children","volume":"31","author":"Bilgi\u00e7","year":"2021","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.09.001","article-title":"Relationship between obsessive compulsive disorder and cortisol: systematic review and meta-analysis","volume":"29","author":"Sousa-Lima","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152329","article-title":"Obsessive-compulsive disorder, insulin signaling and diabetes \u2013 a novel form of physical health comorbidity: the sweet compulsive brain","volume":"117","author":"Grassi","year":"2022","journal-title":"Compr Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000524627","article-title":"Could the thyroid gland dominate the brain in obsessive-compulsive disorder","volume":"112","author":"Caykoylu","year":"2022","journal-title":"Neuroendocrinology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.psyneuen.2017.05.018","article-title":"Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis","volume":"83","author":"Adam","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2006.08.005","article-title":"Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder","volume":"41","author":"Kluge","year":"2007","journal-title":"J Psychiatr Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000123117","article-title":"Diurnal cortisol levels and cortisol response in youths with obsessive-compulsive disorder","volume":"57","author":"Gustafsson","year":"2008","journal-title":"Neuropsychobiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.04.007","article-title":"Dysregulation of neurosteroids in obsessive compulsive disorder","volume":"43","author":"Bigos","year":"2009","journal-title":"J Psychiatr Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00021","article-title":"Perceived stress in obsessive-compulsive disorder is related with obsessive but not compulsive symptoms","volume":"4","author":"Morgado","year":"2013","journal-title":"Front Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10146","article-title":"Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder","volume":"77","author":"\u015eim\u015fek","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-13-0603","article-title":"Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone","volume":"221","author":"McGowan","year":"2014","journal-title":"J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13564","article-title":"Relaxin\u2019 the brain: a case for targeting the nucleus incertus network and relaxin-3\/RXFP3 system in neuropsychiatric disorders","volume":"174","author":"Kumar","year":"2017","journal-title":"Br J Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.06.010","article-title":"Central relaxin-3 receptor (RXFP3) activation reduces elevated, but not basal, anxiety-like behaviour in C57BL\/6J mice","volume":"292","author":"Zhang","year":"2015","journal-title":"Behav Brain Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2022.20.1.135","article-title":"Investigation of relaxin-3 serum levels in terms of social interaction, communication, and appetite as a biomarker in children with autism","volume":"20","author":"Erden","year":"2022","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2021.09.007","article-title":"Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States","volume":"68","author":"Aggarwal","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186969","article-title":"Clinical evidence of antidepressant effects of insulin and anti-hyperglycemic agents and implications for the pathophysiology of depression-a literature review","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262210974","article-title":"Neurobiological mechanisms and therapeutic potential of glucagon-like peptide-1 receptor agonists in binge eating disorder: a narrative review","volume":"26","author":"Tongta","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12888-025-06914-0","article-title":"Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00097","article-title":"Beneficial effects of GLP-1 agonist in a male with compulsive food-related behavior associated with autism","volume":"10","author":"J\u00e4rvinen","year":"2019","journal-title":"Front Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/BF02740625","article-title":"The role of the insulin-like growth factors in the central nervous system","volume":"13","author":"D\u2019Ercole","year":"1996","journal-title":"Mol Neurobiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978708","article-title":"Insulin-like growth factor-I and central nervous system development","volume":"31","author":"Anlar","year":"1999","journal-title":"Horm Metab Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.1993.tb26203.x","article-title":"Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications","volume":"692","author":"Bondy","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/mend-4-5-773","article-title":"Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization--relationship to IGF-I receptors","volume":"4","author":"Werther","year":"1990","journal-title":"Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1385\/MN:21:3:153","article-title":"Serum growth factors and neuroprotective surveillance: focus on IGF-1","volume":"21","author":"Torres-Aleman","year":"2000","journal-title":"Mol Neurobiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1152\/physrev.1987.67.3.962","article-title":"Neural control of somatotropic function","volume":"67","author":"Muller","year":"1987","journal-title":"Physiol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0306-4530(97)00046-2","article-title":"Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients","volume":"22","author":"Deuschle","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2909-05.2005","article-title":"Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor I","volume":"25","author":"Carro","year":"2005","journal-title":"J Neurosci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity","volume":"325","author":"Dyer","year":"2016","journal-title":"Neuroscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000446918","article-title":"Serum levels of insulin-like growth factor-1 and obsessive-compulsive disorder: a case-control study","volume":"74","author":"Rosso","year":"2016","journal-title":"Neuropsychobiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2006.07.002","article-title":"Altered nocturnal growth hormone (GH) secretion in obsessive compulsive disorder","volume":"31","author":"Kluge","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(98)00124-3","article-title":"Growth hormone response to growth hormone-releasing hormone stimulation in obsessive\u2013compulsive disorder","volume":"81","author":"Brambilla","year":"1998","journal-title":"Psychiatry Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijdevneu.2007.09.011","article-title":"Thyroid hormones states and brain development interactions","volume":"26","author":"Ahmed","year":"2008","journal-title":"Int J Dev Neurosci"},{"key":"B41","first-page":"75","article-title":"Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging","volume":"33","author":"Lass","year":"2008","journal-title":"Minerva Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01774.x","article-title":"The thyroid-brain interaction in thyroid disorders and mood disorders","volume":"20","author":"Bauer","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2005.15.581","article-title":"Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment","volume":"15","author":"McCracken","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5455\/apd.178087","article-title":"Thyroid gland functions are affected in obsessive-compulsive disorder","volume":"17","author":"Mermi","year":"2016","journal-title":"Alpha Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J Psychosom Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.11.071","article-title":"Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators","volume":"583","author":"McEwen","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/mp.2014.163","article-title":"The organization of the stress system and its dysregulation in depressive illness","volume":"20","author":"Gold","year":"2015","journal-title":"Mol Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5080\/u23408","article-title":"Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 november 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)","volume":"30","author":"Unal","year":"2019","journal-title":"Turk Psikiyatri Derg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.comppsych.2005.04.005","article-title":"Interrater reliability and clinical efficacy of Children\u2019s Yale-Brown Obsessive-Compulsive Scale in an outpatient setting","volume":"47","author":"Yucelen","year":"2006","journal-title":"Compr Psychiatry"},{"key":"B50","article-title":"Children\u2019s Depression Inventory: a study of reliability and validity","volume":"2","author":"Oy","year":"1991","journal-title":"Turk Psychiatry Derg"},{"key":"B51","volume-title":"Reliability and validity of SCARED in Turkish children","author":"Karaceylan","year":"2005"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.09.014","article-title":"Low hair cortisol concentrations in obsessive compulsive disorder: A cross-sectional study","volume":"131","author":"Koumantarou Malisiova","year":"2020","journal-title":"J Psychiatr Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102164","article-title":"Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder","volume":"53","author":"Ali","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-021-00274-8","article-title":"Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression","volume":"73","author":"Detka","year":"2021","journal-title":"Pharmacol Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-025-00390-x","article-title":"An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders","volume":"3","author":"De Giorgi","year":"2025","journal-title":"Nat Ment Health"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(91)90049-U","article-title":"TRH stimulation test in obsessive-compulsive patients","volume":"38","author":"Aizenberg","year":"1991","journal-title":"Psychiatry Res"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1831156\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:06:49Z","timestamp":1780466809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1831156\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":56,"alternative-id":["10.3389\/fpsyt.2026.1831156"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1831156","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1831156"}}